Article Information
History
- August 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Katja Häkkinen1,2,*,**,
- Wilma Kiander3,*,
- Heidi Kidron3,
- Markku Lähteenvuo1,
- Lea Urpa2,
- Jonne Lintunen1,
- Kati-Sisko Vellonen4,
- Seppo Auriola4,
- Minna Holm5,
- Kaisla Lahdensuo6,
- Olli Kampman7,8,
- Erkki Isometsä9,
- Tuula Kieseppä5,9,
- Jouko Lönnqvist5,10,
- Jaana Suvisaari5,
- Jarmo Hietala11,
- Jari Tiihonen1,12,13,14,
- Aarno Palotie2,15,16,
- Ari V. Ahola-Olli2,15,17,
- Mikko Niemi18,19,20,
- the SUPER-Finland researchers listed in the Acknowledgements
- 1Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, FI-70240 Kuopio, Finland
- 2Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, FI-00014 Helsinki, Finland
- 3Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland
- 4School of Pharmacy, University of Eastern Finland, FI-70211 Kuopio, Finland
- 5Mental Health Team, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland
- 6Mehiläinen Ltd, FI-00260, Helsinki, Finland
- 7Tampere University, FI-33014, Tampere, Finland
- 8Department of Psychiatry, Pirkanmaa Hospital District, FI-33521, Tampere, Finland
- 9Department of Psychiatry, University of Helsinki and Helsinki University Hospital, FI-00029, Helsinki, Finland
- 10Department of Psychiatry, University of Helsinki, FI-00014, Helsinki, Finland
- 11Department of Psychiatry, University of Turku and Turku University Hospital, FI-20521, Turku, Finland
- 12Department of Clinical Neuroscience, Karolinska Institutet, SE-17177 Stockholm, Sweden
- 13Center for Psychiatry Research, Stockholm City Council, SE-11364 Stockholm, Sweden
- 14Neuroscience Center, University of Helsinki, FI-00014, Helsinki, Finland
- 15The Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA-02142, USA
- 16Analytic and Translational Genetics Unit, Department of Medicine, Department of Neurology and Department of Psychiatry, Massachusetts General Hospital, MA-02114 Boston, USA
- 17Satasairaala Hospital, Department of Internal Medicine, FI-28500 Pori, Finland
- 18Department of Clinical Pharmacology, University of Helsinki, FI-00014 Helsinki, Finland
- 19Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, Finland
- 20Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, FI-00029 Helsinki, Finland
- ↵**Corresponding author:
Katja Häkkinen, MSc, katja.hakkinen{at}niuva.fi, Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Niuvankuja 65, FI-70240, Kuopio, Finland
↵* Equal contribution
Posted August 10, 2022.
Functional characterization of six SLCO1B1 (OATP1B1) variants observed in Finnish individuals with a psychotic disorder
